a<p>results for female versus male;</p><p>P, p value for heterogeneity test.</p><p>Results of meta-analysis for CD86 polymorphisms and cancer.</p
a<p>Cochran’s chi-square Q statistic test used to assess the heterogeneity in subgroups.</p>b<p>Coch...
<p>CRC, Colorectal cancer; CASP8, Caspase 8; <i>P<sub>Q</sub></i>, P values of Q-test for heterogene...
<p>Meta-analysis of <i>LTA</i> rs2229094 polymorphism and cancer risk stratified by cancer type.</p
polymorphisms (rs1129055 and rs17281995) in cancer fail to provide compelling evidence. The aim of ...
polymorphisms (rs1129055 and rs17281995) in cancer fail to provide compelling evidence. The aim of ...
Background and Purpose: Previous studies concerning the role of CD86 polymorphisms (rs1129055 and rs...
BACKGROUND AND PURPOSE: Previous studies concerning the role of CD86 polymorphisms (rs1129055 and rs...
<p>Meta-analysis results for the four polymorphisms and breast cancer risk. (OR, odds ratio; CI, con...
<div><p>Background and Purpose</p><p>Previous studies concerning the role of <i>CD86</i> polymorphis...
<p>Meta-analysis of OR for rs10046 polymorphism associated with breast cancer (CT vs.TT).</p
<p><i>P<sub>het</sub></i>: test for heterogeneity; OR: odds ratio; CI: confidence interval; N: numbe...
<p>Funnel plot of publication bias analysis for the associations between CD86 polymorphism and cance...
a<p>Cochran’s chi-square Q statistic test used to assess the heterogeneity in subgroups.</p>b<p>Coch...
<p>OR (95% CI): odds ratio 95% confidence interval; P<sub>het</sub>: P value for heterogeneity; Give...
<p>The results of meta-analysis of <i>rs16835979</i> polymorphisms and ASD risk.</p
a<p>Cochran’s chi-square Q statistic test used to assess the heterogeneity in subgroups.</p>b<p>Coch...
<p>CRC, Colorectal cancer; CASP8, Caspase 8; <i>P<sub>Q</sub></i>, P values of Q-test for heterogene...
<p>Meta-analysis of <i>LTA</i> rs2229094 polymorphism and cancer risk stratified by cancer type.</p
polymorphisms (rs1129055 and rs17281995) in cancer fail to provide compelling evidence. The aim of ...
polymorphisms (rs1129055 and rs17281995) in cancer fail to provide compelling evidence. The aim of ...
Background and Purpose: Previous studies concerning the role of CD86 polymorphisms (rs1129055 and rs...
BACKGROUND AND PURPOSE: Previous studies concerning the role of CD86 polymorphisms (rs1129055 and rs...
<p>Meta-analysis results for the four polymorphisms and breast cancer risk. (OR, odds ratio; CI, con...
<div><p>Background and Purpose</p><p>Previous studies concerning the role of <i>CD86</i> polymorphis...
<p>Meta-analysis of OR for rs10046 polymorphism associated with breast cancer (CT vs.TT).</p
<p><i>P<sub>het</sub></i>: test for heterogeneity; OR: odds ratio; CI: confidence interval; N: numbe...
<p>Funnel plot of publication bias analysis for the associations between CD86 polymorphism and cance...
a<p>Cochran’s chi-square Q statistic test used to assess the heterogeneity in subgroups.</p>b<p>Coch...
<p>OR (95% CI): odds ratio 95% confidence interval; P<sub>het</sub>: P value for heterogeneity; Give...
<p>The results of meta-analysis of <i>rs16835979</i> polymorphisms and ASD risk.</p
a<p>Cochran’s chi-square Q statistic test used to assess the heterogeneity in subgroups.</p>b<p>Coch...
<p>CRC, Colorectal cancer; CASP8, Caspase 8; <i>P<sub>Q</sub></i>, P values of Q-test for heterogene...
<p>Meta-analysis of <i>LTA</i> rs2229094 polymorphism and cancer risk stratified by cancer type.</p
DOI
Add to ORKG